TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Nobel Biocare Norge AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
28,287
|
34,283
|
34,949 |
Financial expenses |
948
|
475
|
199 |
Earnings before taxes |
-656
|
133
|
1,522 |
Total assets |
29,990
|
31,652
|
30,890 |
Current assets |
11,564
|
12,073
|
11,996 |
Current liabilities |
21,821
|
22,354
|
21,966 |
Equity capital |
8,170
|
9,299
|
8,924 |
- share capital |
99
|
106
|
103 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
27.2%
|
29.4%
|
28.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
-2.3%
|
0.4%
|
4.4% |
Return on assets (ROA) |
1.0%
|
1.9%
|
5.6% |
Current ratio |
53.0%
|
54.0%
|
54.6% |
Return on equity (ROE) |
-8.0%
|
1.4%
|
17.1% |
Change turnover |
-3,724
|
-1,749
|
7,086 |
Change turnover % |
-12%
|
-5%
|
25% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.